These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10791551)

  • 41. [Transaminase disorders in asphyxiated term infants: a good neurological marker?].
    Gonzalez de Dios J
    Rev Neurol; 2004 Feb 1-15; 38(3):299-300; author reply 300. PubMed ID: 14963862
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of enzyme results for liver fibrosis evaluation neccessitates standardization.
    Myara A; Guechot J; Lasnier E; Imbert-Bismut F; Voitot H; Ferard G
    Hepatology; 2008 Mar; 47(3):1100-1. PubMed ID: 18266251
    [No Abstract]   [Full Text] [Related]  

  • 43. [HELLP syndrome in the 23d week of pregnancy. A case report and literature discussion].
    Grillo M; Bönig G; Weisner D
    Zentralbl Gynakol; 1990; 112(1):39-43. PubMed ID: 2316293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Validity and use of biological marker tests for alcoholism].
    Aubin HJ
    Rev Prat; 2006 May; 56(10):1065. PubMed ID: 16874952
    [No Abstract]   [Full Text] [Related]  

  • 45. Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation.
    Diedrich F; Renner A; Rath W; Kuhn W; Wieland E
    Am J Obstet Gynecol; 2001 Jul; 185(1):166-72. PubMed ID: 11483923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome.
    Keiser SD; Boyd KW; Rehberg JF; Elkins S; Owens MY; Sunesara I; Martin JN
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1059-63. PubMed ID: 21999898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative hyaluronic acid levels in orthotopic liver transplant recipient.
    Suehiro T; Boros P; Curtiss S; Mor E; Emre S; Sheiner P; Schwartz ME; Miller CM
    Transplant Proc; 1995 Feb; 27(1):1261. PubMed ID: 7878875
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of hepatocellular damage.
    Bernuau J; Erlinger S; Valla D
    Lancet; 2000 Sep; 356(9234):1029-30. PubMed ID: 11041422
    [No Abstract]   [Full Text] [Related]  

  • 49. Proteomic analysis of glutathione S-transferase isoforms in mouse liver mitochondria.
    Sun HD; Ru YW; Zhang DJ; Yin SY; Yin L; Xie YY; Guan YF; Liu SQ
    World J Gastroenterol; 2012 Jul; 18(26):3435-42. PubMed ID: 22807614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrahepatic cholestasis of pregnancy.
    Geenes V; Williamson C
    World J Gastroenterol; 2009 May; 15(17):2049-66. PubMed ID: 19418576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model.
    Duenschede F; Erbes K; Riegler N; Ewald P; Kircher A; Westermann S; Schad A; Miesmer I; Albrecht-Schöck S; Gockel I; Kiemer AK; Junginger T
    World J Gastroenterol; 2007 Jul; 13(27):3692-8. PubMed ID: 17659728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer drugs, genetic variation and the glutathione-S-transferase gene family.
    Townsend D; Tew K
    Am J Pharmacogenomics; 2003; 3(3):157-72. PubMed ID: 12814324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome.
    Steegers EA; Mulder TP; Bisseling JG; Delemarre FM; Peters WH
    Lancet; 1995 Jun; 345(8964):1571-2. PubMed ID: 7791457
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy.
    Knapen MF; Mulder TP; Bisseling JG; Penders RH; Peters WH; Steegers EA
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):161-5. PubMed ID: 9465822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marker for liver damage in neonates born to mothers with HELLP syndrome.
    Knapen M; van Schaijk F; Mulder T; Peters W; Steegers E
    Lancet; 1997 May; 349(9064):1519-20. PubMed ID: 9167466
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic challenges in the evaluation of hepatic grafts from donors with HELLP syndrome: case report and review of the literature.
    Kitchens WH; Adams AB; Hughes CB; Subramanian RM
    Transplant Proc; 2011 Dec; 43(10):4010-2. PubMed ID: 22172890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HELLP syndrome].
    Casper F; Zepp F; Seufert R
    Gynakologe; 1990 Feb; 23(1):29-32. PubMed ID: 2182473
    [No Abstract]   [Full Text] [Related]  

  • 58. A marker for hepatocellular damage.
    Knapen MF; Peters WH; Mulder TP; Steegers EA
    Lancet; 2000 Apr; 355(9213):1463-4. PubMed ID: 10791551
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.